The prevalence and management of anemia in chronic kidney disease patients: Result from the KoreaN Cohort Study for Outcomes in Patients With Chronic Kidney Disease (KNOWCKD)

Journal of Korean Medical Science

Volumn 32, Issue 2, 2017, Pages 249-256

  Ryu, Sang Ryol ^a   Park, Sue K ^b   Jung, Ji Yong ^c   Kim, Yeong Hoon ^d   Oh, Yun Kyu ^e   Yoo, Tae Hyun ^f   Sung, Suah ^g  

^a Department of Internal Medicine   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

^c Gachon University   (South Korea)

^d Inje University College of Medicine   (South Korea)

^e Seoul National University Boramae Hospital   (South Korea)

^f Yonsei University College of Medicine   (South Korea)

^g Eulji University School of Medicine   (South Korea)

Author keywords

Anemia; Chronic kidney disease; Korean

Indexed keywords

ANTIANEMIC AGENT; FERRITIN; HEMOGLOBIN;

ADULT; AGED; ANEMIA; ASIAN CONTINENTAL ANCESTRY GROUP; BODY MASS; COHORT ANALYSIS; COMPLICATION; DIABETIC NEPHROPATHY; FEMALE; HUMAN; MALE; MIDDLE AGED; ODDS RATIO; PATHOLOGY; RENAL INSUFFICIENCY, CHRONIC; RISK FACTOR; SEVERITY OF ILLNESS INDEX; SMOKING; SOUTH KOREA; STATISTICAL MODEL;

ADULT; AGED; ANEMIA; ASIAN CONTINENTAL ANCESTRY GROUP; BODY MASS INDEX; COHORT STUDIES; DIABETIC NEPHROPATHIES; FEMALE; FERRITINS; HEMATINICS; HEMOGLOBINS; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; RENAL INSUFFICIENCY, CHRONIC; REPUBLIC OF KOREA; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SMOKING;

EID: 85011685225     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2017.32.2.249     Document Type: Article

References (29)

1. Smith RE Jr. The clinical and economic burden of anemia. Am J Manag Care 2010; 16 Suppl Issues: S59-66.
2. van Nooten FE, Green J, Brown R, Finkelstein FO, Wish J. Burden of illness for patients with non-dialysis chronic kidney disease and anemia in the United States: review of the literature. J Med Econ 2010; 13: 241-56.
3. Farag YM, Keithi-Reddy SR, Mittal BV, Surana SP, Addabbo F, Goligorsky MS, Singh AK. Anemia, inflammation and health-related quality of life in chronic kidney disease patients. Clin Nephrol 2011; 75: 524-33.
4. Iseki K, Kohagura K. Anemia as a risk factor for chronic kidney disease. Kidney Int Suppl 2007: S4-9.
5. Kurella Tamura M, Vittinghoff E, Yang J, Go AS, Seliger SL, Kusek JW, Lash J, Cohen DL, Simon J, Batuman V, et al. Anemia and risk for cognitive decline in chronic kidney disease. BMC Nephrol 2016; 17: 13.
6. Babitt JL, Lin HY. Mechanisms of anemia in CKD. J Am Soc Nephrol 2012; 23: 1631-4.
7. Astor BC, Muntner P, Levin A, Eustace JA, Coresh J. Association of kidney function with anemia: the Third National Health and Nutrition Examination Survey (1988-1994). Arch Intern Med 2002; 162: 1401-8.
8. Stauffer ME, Fan T. Prevalence of anemia in chronic kidney disease in the United States. PLoS One 2014; 9: e84943.
9. Li Y, Shi H, Wang WM, Peng A, Jiang GR, Zhang JY, Ni ZH, He LQ, Niu JY, Wang NS, et al. Prevalence, awareness, and treatment of anemia in Chinese patients with nondialysis chronic kidney disease: First multicenter, cross-sectional study. Medicine (Baltimore) 2016; 95: e3872.
10. Kwen JH, Cho S, Kim SR. The study of anemia in stable chronic kidney disease patients not receiving dialysis treatment. Korean J Nephrol 2003; 22: 63-72.
11. Oh KH, Park SK, Park HC, Chin HJ, Chae DW, Choi KH, Han SH, Yoo TH, Lee K, Kim YS, et al. KNOW-CKD (Korean cohort study for outcome in patients with chronic kidney disease): design and methods. BMC Nephrol 2014; 15: 80.
12. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373-83.
13. Levey AS, Coresh J, Greene T, Stevens LA, Zhang YL, Hendriksen S, Kusek JW, Van Lente F; Chronic Kidney Disease Epidemiology Collaboration. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 2006; 145: 247-54.
14. Chapter 1: definition and classification of CKD. Kidney Int Suppl (2011) 2013; 3: 19-62.
15. Chapter 1: diagnosis and evaluation of anemia in CKD. Kidney Int Suppl (2011) 2012; 2: 288-91.
16. Akizawa T, Makino H, Matsuo S, Watanabe T, Imai E, Nitta K, Ohashi Y, Hishida A; Chronic Kidney Disease Japan Cohort Study Group. Management of anemia in chronic kidney disease patients: baseline findings from Chronic Kidney Disease Japan Cohort Study. Clin Exp Nephrol 2011; 15: 248-57.
17. New JP, Aung T, Baker PG, Yongsheng G, Pylypczuk R, Houghton J, Rudenski A, New RP, Hegarty J, Gibson JM, et al. The high prevalence of unrecognized anaemia in patients with diabetes and chronic kidney disease: a population-based study. Diabet Med 2008; 25: 564-9.
18. Fioretto P, Mauer M, Brocco E, Velussi M, Frigato F, Muollo B, Sambataro M, Abaterusso C, Baggio B, Crepaldi G, et al. Patterns of renal injury in NIDDM patients with microalbuminuria. Diabetologia 1996; 39: 1569-76.
19. Catrina SB, Okamoto K, Pereira T, Brismar K, Poellinger L. Hyperglycemia regulates hypoxia-inducible factor-1alpha protein stability and function. Diabetes 2004; 53: 3226-32.
20. Jee SH, Sull JW, Park J, Lee SY, Ohrr H, Guallar E, Samet JM. Body-mass index and mortality in Korean men and women. N Engl J Med 2006; 355: 779-87.
21. Tran L, Batech M, Rhee CM, Streja E, Kalantar-Zadeh K, Jacobsen SJ, Sim JJ. Serum phosphorus and association with anemia among a large diverse population with and without chronic kidney disease. Nephrol Dial Transplant 2016; 31: 636-45.
22. Patel NM, Gutiérrez OM, Andress DL, Coyne DW, Levin A, Wolf M. Vitamin D deficiency and anemia in early chronic kidney disease. Kidney Int 2010; 77: 715-20.
23. Qunibi WY, Martinez C, Smith M, Benjamin J, Mangione A, Roger SD. A randomized controlled trial comparing intravenous ferric carboxymaltose with oral iron for treatment of iron deficiency anaemia of non-dialysis-dependent chronic kidney disease patients. Nephrol Dial Transplant 2011; 26: 1599-607.
24. KDOQI; National Kidney Foundation. KDOQI clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease. Am J Kidney Dis 2006; 47: S11-145.
25. Fishbane S, Pollack S, Feldman HI, Joffe MM. Iron indices in chronic kidney disease in the National Health and Nutritional Examination Survey 1988-2004. Clin J Am Soc Nephrol 2009; 4: 57-61.
26. Panwar B, Gutiérrez OM. Disorders of iron metabolism and anemia in chronic kidney disease. Semin Nephrol 2016; 36: 252-61.
27. Kuo KL, Hung SC, Lee TS, Tarng DC. Iron sucrose accelerates early atherogenesis by increasing superoxide production and upregulating adhesion molecules in CKD. J Am Soc Nephrol 2014; 25: 2596-606.
28. Kang J, Park J, Lee JM, Park JJ, Choi DJ. The effects of erythropoiesis stimulating therapy for anemia in chronic heart failure: a meta-analysis of randomized clinical trials. Int J Cardiol 2016; 218: 12-22.
29. Welborn J. Review: erythropoietin or darbepoetin for anemia in patients with cancer produces both benefits and harms with no increase in survival. ACP J Club 2007; 146: 6.